From wiki:
Imugene began as a research project in the laboratory of Professor Ursula Wiedermann at the Medical University of Vienna. Over the nine years from 2004 Wiedermann et al. had developed a B cell peptide cancer immunotherapy that could induce an antibody response targeting HER-2 overexpressing tumours. In 2012 a start-up company called Biolife Science had been incorporated to develop this immunotherapy. Early-stage funding was secured from Australian and US investors in 2013, after which Biolife was taken public in December 2013 in a reverse takeover of an Australian drug development company called Imugene, whose name was retained after the merger
- Forums
- Charts
- Charting Only.
From wiki: Imugene began as a research project in the laboratory...
-
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
-0.004(5.83%) |
Mkt cap ! $440.9M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.6¢ | $565.8K | 9.807M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 1109145 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 695862 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 1082484 | 0.056 |
27 | 1914686 | 0.055 |
17 | 2447216 | 0.054 |
16 | 2786915 | 0.053 |
16 | 1157242 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 494419 | 5 |
0.058 | 589658 | 8 |
0.059 | 381479 | 8 |
0.060 | 3977547 | 11 |
0.061 | 475000 | 6 |
Last trade - 10.32am 24/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online